britannia pharmaceuticals
Reading
We continue to redefine and innovate drug delivery methods for Parkinson’s and
other disorders, and are committed to combining research and development
excellence with world-class patient care, through caring for peoples health as a
trusted partner. Britannia puts its people at the heart of everything we do and
ensures that our values and behaviours are lived every day. Britannia grew a lot
the last few years and will continue to do so into new markets which makes it an
exciting time to join the company! VASILIKI PAPACHRISTOPOULOU, INTERNATIONAL
PRODUCT MANAGER For more than 30 years, our primary field of interest has been
the development of innovative, patient-centric technology that effectively
delivers therapies to patients with Parkinson’s disease. We work with specialist
focus groups, fund clinical trials and invest in care initiatives that optimise
treatment programmes and improve quality of life. Britannia Pharmaceuticals Ltd.
has undergone a large growth in the past 30 years, and operates as the global
specialty centre for Parkinson’s Disease in the STADA Network. Read about
journey from a small, family run business, to sharing products internationally.